Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | SEPN Septerna, Inc. | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $38.05 -2.8% | $15.90 -2.5% |
| StockIQ Score | 54C- Moderate Risk: High | 41D Weak Risk: High |
| Technical | 41D | 36F |
| Fundamental | 30F | 35F |
| Growth | 82A- | 50C- |
| Fair Value | 62C+ | 38F |
| News | 100A+ | 50C- |
| Quality | 42D | 50C- |
| Risk | 40D | 40D |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
Septerna (SEPN) outperforms Ascentage Pharma (AAPG) in growth and valuation, with scores of 82 and 62 versus 50 and 38. However, AAPG has a stronger investor and technical score (41 vs. 36 and 36 vs. 41). SEPN’s overall rating is moderate, while AAPG is weak, reflecting its lower consistency across categories.
